<DOC>
	<DOCNO>NCT00223743</DOCNO>
	<brief_summary>The purpose pilot study obtain information whether medication zonisamide reduce tremor person essential tremor well tolerate .</brief_summary>
	<brief_title>A Safety/Efficacy Trial Zonisamide Essential Tremor</brief_title>
	<detailed_description>Essential tremor common , affect four percent population age 40 year . Of , half troublesome tremor warrant medical therapy , half find satisfactory treatment . Thus estimate one million Americans able find adequate therapy essential tremor . Presently used medication may fail due lack efficacy tolerance . After encounter anecdotal experience zonisamide 's efficacy essential tremor decide conduct single-site open-treatment rising-dose study blind videotape rating tremor . Zonisamide presently market United States epilepsy . Its use condition experimental . Healthy participant bilateral hand tremor initially sign IRB-approved inform consent form , assessment Screening Visit determine healthy ( physical neurological examination , routine blood test , electrocardiogram ) tremor assessment rating scale . Tremor visit videotape , well assess openly rater . If participant meet eligibility criterion , return Baseline Visit ( Visit 1 ) repeat tremor assessment initial dispensation zonisamide . The study drug initially take one 50-mg tablet day , dose increase one tablet two week , 3 tablet ( 150 mg ) take twice day . During 12-week dose adjustment phase , participant see clinic 4 week tremor assessment review health status . In addition , participant contact telephone week . If symptom occurs suggestive side effect , escalation stop dose reduce order resolve symptom . At end 12-week dose adjustment phase , Visit 4 , determine whether meaningful tremor reduction occur target dose 300 mg per day lesser tolerate dose . If , participant discontinue study . If benefit occur , subject invite continue take zonisamide another 12 week , conclusion participant see final visit ( Visit 5 ) . The videotape cod order make apparent , degree tremor rat rater know study participant .</detailed_description>
	<mesh_term>Tremor</mesh_term>
	<mesh_term>Essential Tremor</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<criteria>age 18 old diagnosis essential tremor tremor present hand least one year tremor bothersome least one hand , reduction tremor would improve quality life able comply study visit procedure voluntarily sign consent form able abstain alcohol 12 hour prior visit , caffeine day prior visit take medication stable dos antitremor medication 4 week prior Baseline visit medical condition likely cause hospitalization study progressive neurological disorder essential tremor history serious psychiatric illness history drug alcohol abuse past year consumes two glass wine equivalent per day receive botulinum toxin injection past 6 month currently use experimental device take experimental drug within 5 half life elimination receive deep brain stimulation past two week potential need therapy study thalamotomy within past 6 month take medication judge investigator exacerbate tremor probable cause tremor essential tremor condition likely interfere absorption , metabolism elimination study drug hepatic disease renal disease history renal stone history allergy sulfonamide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>essential tremor</keyword>
	<keyword>zonisamide</keyword>
	<keyword>clinical trial</keyword>
</DOC>